1. Home
  2. IMMP vs GENC Comparison

IMMP vs GENC Comparison

Compare IMMP & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • GENC
  • Stock Information
  • Founded
  • IMMP 1987
  • GENC 1894
  • Country
  • IMMP Australia
  • GENC United States
  • Employees
  • IMMP N/A
  • GENC N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • GENC Construction/Ag Equipment/Trucks
  • Sector
  • IMMP Health Care
  • GENC Industrials
  • Exchange
  • IMMP Nasdaq
  • GENC Nasdaq
  • Market Cap
  • IMMP 251.8M
  • GENC 240.4M
  • IPO Year
  • IMMP N/A
  • GENC N/A
  • Fundamental
  • Price
  • IMMP $1.68
  • GENC $15.06
  • Analyst Decision
  • IMMP Buy
  • GENC
  • Analyst Count
  • IMMP 1
  • GENC 0
  • Target Price
  • IMMP $7.00
  • GENC N/A
  • AVG Volume (30 Days)
  • IMMP 88.5K
  • GENC 39.6K
  • Earning Date
  • IMMP 10-21-2025
  • GENC 08-08-2025
  • Dividend Yield
  • IMMP N/A
  • GENC N/A
  • EPS Growth
  • IMMP N/A
  • GENC N/A
  • EPS
  • IMMP N/A
  • GENC 1.03
  • Revenue
  • IMMP $3,306,742.00
  • GENC $117,527,000.00
  • Revenue This Year
  • IMMP N/A
  • GENC N/A
  • Revenue Next Year
  • IMMP $725.37
  • GENC N/A
  • P/E Ratio
  • IMMP N/A
  • GENC $14.62
  • Revenue Growth
  • IMMP 31.28
  • GENC 3.90
  • 52 Week Low
  • IMMP $1.32
  • GENC $10.80
  • 52 Week High
  • IMMP $2.71
  • GENC $22.82
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 50.03
  • GENC 45.82
  • Support Level
  • IMMP $1.60
  • GENC $14.66
  • Resistance Level
  • IMMP $1.76
  • GENC $15.48
  • Average True Range (ATR)
  • IMMP 0.06
  • GENC 0.57
  • MACD
  • IMMP 0.01
  • GENC -0.15
  • Stochastic Oscillator
  • IMMP 52.94
  • GENC 23.95

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

Share on Social Networks: